Editors:
- Includes cutting-edge methods and protocols
- Provides step-by-step detail essential for reproducible results
- Contains key notes and implementation advice from the experts
Part of the book series: Methods in Molecular Biology (MIMB, volume 1750)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (27 protocols)
-
Front Matter
-
The Need for Alzheimer’s Disease Biomarkers
-
Front Matter
-
-
Innovative Approaches to Cerebrospinal Fluid Biomarker Discovery
-
Front Matter
-
-
Novel Blood-Based Biomarkers
-
Front Matter
-
-
Magnetic Resonance Imaging Methods
-
Front Matter
-
-
Molecular Imaging Approaches
-
Front Matter
-
About this book
This volume aims to build a new generation of experts with a broader understanding of key topics in the Alzheimer’s disease field. Chapters guide readers through innovative approaches to the discovery of novel biomarkers in cerebrospinal fluid, innovation in blood-based biomarkers, a comprehensive overview of magnetic resonance imaging and molecular imaging approaches and their value for developing drugs for Alzheimer’s disease, cutting-edge developments in neuropathology and their relevance for Alzheimer’s disease trials, novel genomic strategies for biomarker development, and related topics including neuropsychological testing and advanced analytical methods.Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.
Authoritative and cutting-edge, Biomarkers for Alzheimer's Disease Drug Development aims to ensure successful results in the further study of this vital field.
Editors and Affiliations
-
Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität München, Munich, Germany
Robert Perneczky
Bibliographic Information
Book Title: Biomarkers for Alzheimer’s Disease Drug Development
Editors: Robert Perneczky
Series Title: Methods in Molecular Biology
DOI: https://doi.org/10.1007/978-1-4939-7704-8
Publisher: Humana New York, NY
eBook Packages: Springer Protocols
Copyright Information: Springer Science+Business Media, LLC 2018
Hardcover ISBN: 978-1-4939-7703-1Published: 07 March 2018
Softcover ISBN: 978-1-4939-9262-1Published: 14 August 2020
eBook ISBN: 978-1-4939-7704-8Published: 06 March 2018
Series ISSN: 1064-3745
Series E-ISSN: 1940-6029
Edition Number: 1
Number of Pages: XV, 372
Number of Illustrations: 9 b/w illustrations, 45 illustrations in colour
Topics: Pharmacology/Toxicology